Search research articles
Contact Us
Filters
Showing results (61-70 of 126) with videos related to
Page
of 13
Sort By:
Blood Pressure
|
August 6, 2010
Blood pressure variability: Emerging role in risk assessment and therapeutics
Suzanne Oparil, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
May 3, 2013
Revisiting the pre-hypertension debate: increasing evidence for treatment--or not?
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
December 6, 2012
Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
May 11, 2013
Primary cardiovascular prevention by Mediterranean diet - the PREDIMED trial
Thomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure
|
May 21, 2014
Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
Sverre E Kjeldsen, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure
|
May 21, 2010
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
September 1, 2010
The J-curve phenomenon revisited
Thomas Hedner, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Blood Pressure. Supplement
|
February 11, 2009
More focus on therapeutic targets and improved tolerability in hypertension
Thomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
July 7, 2007
Blood pressure control--slowly getting there through new strategies?
Thomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
February 5, 2009
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Suzanne Oparil, Sverre E Kjeldsen, Thomas Hedner, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 126) with videos related to
Sort By:
Page
of 13
Blood Pressure
|
August 6, 2010
Blood pressure variability: Emerging role in risk assessment and therapeutics
Suzanne Oparil, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
May 3, 2013
Revisiting the pre-hypertension debate: increasing evidence for treatment--or not?
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
December 6, 2012
Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
May 11, 2013
Primary cardiovascular prevention by Mediterranean diet - the PREDIMED trial
Thomas Hedner, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure
|
May 21, 2014
Renal denervation in treatment-resistant hypertension - Oslo RDN, Symplicity HTN-3 and INSPiRED randomized trials
Sverre E Kjeldsen, Krzysztof Narkiewicz, Suzanne Oparil, et al.
Blood Pressure
|
May 21, 2010
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research
Sverre E Kjeldsen, Thomas Hedner, Krzysztof Narkiewicz, et al.
Blood Pressure
|
September 1, 2010
The J-curve phenomenon revisited
Thomas Hedner, Suzanne Oparil, Krzysztof Narkiewicz, et al.
Blood Pressure. Supplement
|
February 11, 2009
More focus on therapeutic targets and improved tolerability in hypertension
Thomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
July 7, 2007
Blood pressure control--slowly getting there through new strategies?
Thomas Hedner, Sverre E Kjeldsen, Krzysztof Narkiewicz, et al.
Blood Pressure
|
February 5, 2009
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Suzanne Oparil, Sverre E Kjeldsen, Thomas Hedner, et al.
Page
of 13